Cite

    Lamb, L. et al. (2018). Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis. Bone marrow transplantation. pp. 766-769. [Online].